Summary (tl;dr)

Medline, a prominent global medical supplies company, has made headlines with the largest Initial Public Offering (IPO) of 2025, successfully raising $6.26 billion as its stock, MDLN, began trading and surged on the Nasdaq.

Essential Background

Founded in 1966, Medline Industries has grown into a major manufacturer and distributor of an extensive range of medical and surgical products, offering over 335,000 items globally. In 2021, a consortium of private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, acquired Medline in a substantial $34 billion leveraged buyout. The current IPO represents a significant move for these private equity owners to realize value from their investment. This IPO also comes after a tumultuous year for the U.S. stock markets in 2025, which saw disruptions from government-related events and economic factors like inflation.

The Full Story

On December 17, 2025, Medline officially debuted on the Nasdaq Global Select Market under the ticker symbol "MDLN," after pricing its upsized initial public offering at $29 per share. The company successfully raised approximately $6.26 billion, solidifying its position as the largest initial public offering globally in 2025 and surpassing all other listings for the year. Investor demand for Medline's shares was exceptionally strong, with the offering reportedly being more than ten times oversubscribed. Following its debut, Medline's stock experienced a significant surge, opening around $35 and quickly rising to over $37, marking a substantial increase from its initial public offering price.

Why It Matters

Medline's highly successful IPO, being the largest of 2025, is seen as a significant indicator of renewed investor confidence in large, private equity-backed companies seeking public listings, potentially paving the way for more such offerings in 2026 following a challenging year for the IPO market. The strong performance of Medline's stock on its debut also reflects robust investor interest in the medical supply sector and financially sound issuers. This event provides substantial liquidity for its private equity owners and allows Medline to reduce its outstanding debt while investing in future corporate initiatives. The company's CEO noted that the IPO is expected to enhance Medline's brand and support its strategy to become the "Costco of healthcare" through its private label products, extensive supply chain, and strong customer relationships.

Geographic Location

• Northfield, Cook County, Illinois, United States (Medline headquarters and location of IPO announcement)
• New York City, New York County, New York, United States (Nasdaq Global Select Market listing and trading debut)